Skip to main content
iwCLL 2023 Main banner
Final Program


iwCLL X / Twitter
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

John F. Seymour, MBBS, FRACP, PhD

Director of Department of Haematology
Royal Melbourne Hospital, Peter MacCallum Cancer Centre and University of Melbourne
Melbourne, Victoria, Australia

Professor John Seymour MB BS FRACP PhD AM is the Director of the Department of Haematology of the Peter MacCallum Cancer Centre & the Royal Melbourne Hospital in Melbourne, Australia. He graduated from the University of Melbourne and completed a translational research fellowship at the MD Anderson Cancer Center, subsequently receiving their Distinguished Alumnus award. He has a PhD for research on the pathobiology of haematopoietic growth factors conducted at the Ludwig Institute for Cancer Research. Professor Seymour is a Vincent Fairfax Fellow in Ethical Leadership, co-chair of the Australian national Blood Cancer Taskforce and a member of several international scientific committees including, the Scientific Boards of the International Workshop on CLL, and Hairy Cell Leukemia Foundation, Scientific Advisory Committee for the International Conference on Malignant Lymphoma, Medical Advisory Board of the Lymphoma Coalition, and the Board of Directors of the International Extranodal Lymphoma Study Group. For over a decade he served asExecutive member and Chairman of the major national clinical trials co-operative group in haematologic malignancies, the Australasian Leukaemia & Lymphoma Group, and 6 years as Associate Director of Research (Clinical) for Peter Mac. Committed to academic publishing he is an Editor-in-Chief of Leukemia & Lymphoma, currently on the editorial boards of eight academic journals including the BJH, and previously on Blood, Haematologica and JCO. He has authored 23 book chapters, >600 peer reviewed publications (with >50,000 literature citations; h-index=98), and >900 conference abstracts. Actively involved in a broad range of clinical and translational research, Professor Seymour has been the principal investigator on >90 clinical trials and chief investigator on competitive grants awarded >AUD$90 million funding in the last decade. In 2015 he was awarded Membership of the Order of Australia and elected to the Australian Academy of Health and Medical Sciences for his contributions to the field.

Presentation(s):